International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICRTET-4
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 5
September-October 2026
Indexing Partners
Albumin–Fibrinogen Ratio and C-Reactive Protein–Albumin Ratio as Markers of Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Study
| Author(s) | Dr. Dhruv Roopkishore Pathak |
|---|---|
| Country | India |
| Abstract | Background: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease in which accurate assessment of disease activity is essential for treatment monitoring. Conventional inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) have recognized limitations. The albumin–fibrinogen ratio (AFR) and CRP–albumin ratio (CAR) combine positive and negative acute-phase reactants and may provide complementary information about inflammatory burden. Objective: To evaluate AFR and CAR as markers of disease activity in patients with RA and to assess their association with the Disease Activity Score-28 (DAS28). Methods: This observational cross-sectional study was conducted in the Department of General Medicine at Jaipur Golden Hospital, Rohini, New Delhi. Forty-eight adults fulfilling the ACR/EULAR 2010 classification criteria for RA were included. Disease activity was assessed using DAS28-ESR, and participants were categorized into active disease or remission. Serum albumin, fibrinogen, CRP, ESR and hemoglobin were measured. AFR and CAR were calculated, and group comparisons, correlation analysis, multivariable logistic regression and receiver operating characteristic (ROC) analysis were performed. Results: Among 48 participants, 24 (50.0%) had active disease and 24 (50.0%) were in remission. AFR was significantly lower in active disease than in remission (8.63 ± 2.05 vs. 12.69 ± 2.92; p < 0.0001). CAR was significantly higher in active disease [median 0.36 (IQR 0.325–1.044)] than in remission [0.15 (IQR 0.032–0.329); p = 0.0006]. AFR showed a significant moderate negative correlation with DAS28 (r = −0.521, p = 0.0002), whereas CAR showed a significant positive correlation (r = 0.385, p = 0.007). For discrimination of active disease, AFR had an area under the ROC curve (AUC) of 0.875 (95% CI 0.779–0.971), with 87.5% sensitivity and 75.0% specificity at a cutoff of ≤11.1436. CAR had an AUC of 0.788 (95% CI 0.658–0.918). Conclusion: In this study population, lower AFR and higher CAR were associated with greater RA disease activity. Both ratios may serve as accessible adjunctive inflammatory indices alongside established clinical disease activity measures. The findings require confirmation in larger, longitudinal studies before routine use as independent disease-activity biomarkers. |
| Keywords | rheumatoid arthritis, albumin–fibrinogen ratio, CRP–albumin ratio, disease activity, DAS28, inflammation, biomarkers |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 5, September-October 2026 |
| Published On | 2026-10-03 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals